Adaptive Biotechnologies Corp
Recent Filings
All 741 filings →| Form | Description | Date |
|---|---|---|
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 26, 2026 |
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 23, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 18, 2026 |
| 144 | — | Mar 16, 2026 |
| 144 | — | Mar 16, 2026 |
| 144 | — | Mar 16, 2026 |
| 144 | — | Mar 16, 2026 |
| 144 | — | Mar 16, 2026 |
| 144 | — | Mar 16, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| HERSHBERG ROBERT | — | Sale | 22,968 @ $16.00 | 46,722 | Dec 10, 2025 |
| ROBINS HARLAN S | Chief Scientific Officer | Sale | 10,000 @ $16.61 | 1,232,312 | Dec 3, 2025 |
| ROBINS CHAD M | CEO and Chairman | Sale | 35,736 @ $19.68 | 2,834,239 | Dec 1, 2025 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Sale | 297,925 @ $16.54 | 296,791 | Nov 21, 2025 |
| PISKEL KYLE | Chief Financial Officer | Sale | 238 @ $14.05 | 269,343 | Nov 17, 2025 |
| ROBINS CHAD M | CEO and Chairman | Sale | 86,161 @ $14.73 | 2,873,088 | Nov 11, 2025 |
| ROBINS HARLAN S | Chief Scientific Officer | Sale | 10,000 @ $14.82 | 1,269,524 | Nov 10, 2025 |
| PISKEL KYLE | Chief Financial Officer | Sale | 1,929 @ $8.89 | 269,581 | May 16, 2025 |
| PISKEL KYLE | Chief Financial Officer | Award / Grant | 7,815 | 279,325 | May 16, 2025 |
| GRIFFIN MICHELLE RENEE | — | Sale | 36,291 @ $7.19 | 15,394 | Mar 13, 2025 |